Osuga Tatsuyuki, Nakamura Kensuke, Morita Tomoya, Lim Sue Yee, Yokoyama Nozomu, Morishita Keitaro, Ohta Hiroshi, Takiguchi Mitsuyoshi
Am J Vet Res. 2015 Aug;76(8):702-9. doi: 10.2460/ajvr.76.8.702.
To evaluate the effects of dobutamine, esmolol, milrinone, and phenylephrine on left atrial phasic function of healthy dogs.
9 healthy Beagles.
Following sedation with propofol on each of 4 experimental days, dogs were administered a constant rate infusion of dobutamine (5 μg/kg/min), esmolol (500 μg/kg/min), milrinone (25 μg/kg, IV bolus, followed by 0.5 μg/kg/min), or phenylephrine (2 μg/kg/min). There was at least a 14-day interval between experimental days. Each drug was administered to 6 dogs. Conventional and 2-D speckle tracking echocardiography were performed before (baseline) and after administration of the cardiovascular drug, and time-left atrial area curves were derived to calculate indices for left atrial reservoir, conduit, and booster pump functions (left atrial phasic function) and left ventricular contractility and lusitropy.
Compared with baseline values, indices for left atrial reservoir and booster pump functions and left ventricular contractility and lusitropy were significantly increased following dobutamine administration; indices for left atrial phasic function and left ventricular lusitropy were changed insignificantly, and indices for left ventricular contractility were significantly impaired following esmolol administration; indices for left atrial phasic function and left ventricular relaxation were changed insignificantly, and indices for left ventricular systolic function were significantly augmented following milrinone administration; and indices for left atrial phasic function and left ventricular lusitropy were changed insignificantly, and indices of ventricular contractility were significantly impaired following phenylephrine administration.
Results indicated that, following administration of dobutamine, esmolol, milrinone, or phenylephrine to healthy dogs, left atrial phasic function indices were fairly stable and did not parallel changes in left ventricular function indices.
评估多巴酚丁胺、艾司洛尔、米力农和去氧肾上腺素对健康犬左心房阶段性功能的影响。
9只健康的比格犬。
在4个实验日的每一天,用丙泊酚镇静后,给犬持续输注多巴酚丁胺(5微克/千克/分钟)、艾司洛尔(500微克/千克/分钟)、米力农(25微克/千克,静脉推注,随后0.5微克/千克/分钟)或去氧肾上腺素(2微克/千克/分钟)。实验日之间至少间隔14天。每种药物给予6只犬。在给予心血管药物之前(基线)和之后进行传统及二维斑点追踪超声心动图检查,并得出左心房面积随时间变化的曲线,以计算左心房储存、管道和增强泵功能(左心房阶段性功能)以及左心室收缩性和舒张性的指标。
与基线值相比,多巴酚丁胺给药后左心房储存和增强泵功能以及左心室收缩性和舒张性指标显著增加;艾司洛尔给药后左心房阶段性功能和左心室舒张性指标变化不显著,左心室收缩性指标显著受损;米力农给药后左心房阶段性功能和左心室舒张指标变化不显著,左心室收缩功能指标显著增强;去氧肾上腺素给药后左心房阶段性功能和左心室舒张性指标变化不显著,心室收缩性指标显著受损。
结果表明,对健康犬给予多巴酚丁胺、艾司洛尔、米力农或去氧肾上腺素后,左心房阶段性功能指标相当稳定,与左心室功能指标的变化不平行。